|Assessment Status||Rapid Review complete|
|Indication||For the treatment of complicated urinary tract infections (cUTI), acute pyelonephritis and complicated intra-abdominal infections (cIAI) in adults.|
|Rapid review commissioned||03/03/2016|
|Rapid review completed||26/04/2016|
|Rapid review outcome||Full Pharmacoeconomic Evaluation recommended at the Submitted Price.|
The HSE has approved reimbursement following confidential price negotiations.